Lean mass loss on GLP-1 receptor agonists: a downside of the “miracle drugs”

Seems that in the 2 studies that differentiate between fat mass and lean mass lost, patients lost about 40% of their weight in lean mass. This is suboptimal, if maybe a worth-while trade off for some.